|
US5912347A
(en)
*
|
1996-09-30 |
1999-06-15 |
Mallinckrodt Inc. |
Process for preparing a morphinan derivative
|
|
WO2000066588A1
(en)
*
|
1999-05-05 |
2000-11-09 |
The Government Of The United States Of America, Represented By The Secretary, Departmentof Health A Nd Human Services |
Direct c-14 oxidation of opioids
|
|
US6177567B1
(en)
*
|
1999-10-15 |
2001-01-23 |
Boehringer Ingelheim Chemicals, Inc. |
Method for preparing oxycodone
|
|
CN1271072C
(zh)
*
|
2001-08-23 |
2006-08-23 |
阿克佐诺贝尔公司 |
14－羟基去吗啡酮衍生物的制备方法
|
|
JP3961796B2
(ja)
*
|
2001-08-27 |
2007-08-22 |
ソニー株式会社 |
情報提供システム、情報処理装置および方法、情報提供装置および方法、記録媒体、並びにプログラム
|
|
DE10161963A1
(de)
*
|
2001-12-17 |
2003-07-03 |
Johannes Schuetz |
6-Aminomorphinanderivate, Herstellungsverfahren dafür und deren Verwendung
|
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
|
US20040058946A1
(en)
*
|
2002-07-05 |
2004-03-25 |
Buchwald Stephen L. |
Abuse-resistant prodrugs of oxycodone and other pharmaceuticals
|
|
RU2236412C2
(ru)
*
|
2002-07-18 |
2004-09-20 |
Власов Михаил Иванович |
Способ получения производных морфинона, способ получения производных 14-гидроксиморфинона, и способ получения производных оксиморфона
|
|
RU2215742C1
(ru)
*
|
2002-11-05 |
2003-11-10 |
Открытое Акционерное Общество "Международная Научно-Технологическая Корпорация" |
Способ получения сложных эфиров n-замещенных 14-гидроксиморфинанов
|
|
RU2215741C1
(ru)
*
|
2002-11-05 |
2003-11-10 |
Открытое Акционерное Общество "Международная Научно-Технологическая Корпорация" |
Сложные эфиры n-замещенных 14-гидроксиморфинанов и способ их получения
|
|
DE60329520D1
(de)
*
|
2002-11-08 |
2009-11-12 |
Mallinckrodt Inc |
Verfahren zur herstellung von quaternäre n-alkyl morphinan alkaloid salzen
|
|
CA2779723C
(en)
*
|
2002-12-13 |
2014-03-25 |
Durect Corporation |
Oral drug delivery system
|
|
US6790959B1
(en)
|
2003-06-05 |
2004-09-14 |
Halsey Drug Company, Inc. |
Process for manufacturing thebaine
|
|
US6864370B1
(en)
|
2003-06-05 |
2005-03-08 |
Zhaiwei Lin |
Process for manufacturing oxycodone
|
|
HUE034668T2
(hu)
|
2003-09-22 |
2018-02-28 |
Glaxosmithkline Australia Pty Ltd |
Eljárás morfinán-származékok szintézisére és azok intermedierjei
|
|
US7875718B2
(en)
*
|
2003-09-22 |
2011-01-25 |
Johnson Matthey Public Limited Company |
Process for the synthesis of morphinane compounds and intermediates thereof
|
|
AP2006003716A0
(en)
*
|
2004-02-06 |
2006-08-31 |
Euro Celtique Sa |
Methods for making 3-O-protected morphines and 3-O-protected morphinone dienol carboxylates
|
|
TW201509943A
(zh)
|
2004-03-30 |
2015-03-16 |
Euro Celtique Sa |
含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽之組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
|
|
SK286047B6
(sk)
*
|
2004-04-13 |
2008-01-07 |
Zentiva, A. S. |
Spôsob prípravy derivátov 4,5alfa-epoxy-6-oxomorfínanu
|
|
US6946556B1
(en)
*
|
2004-05-21 |
2005-09-20 |
Acura Pharmaceuticals, Inc. |
Preparation of opioid analgesics by a one-pot process
|
|
JP2008501797A
(ja)
*
|
2004-06-08 |
2008-01-24 |
マリンクロッド・インコーポレイテッド |
アヘンからのアルカロイド類の抽出
|
|
PT1765292T
(pt)
|
2004-06-12 |
2017-12-29 |
Collegium Pharmaceutical Inc |
Formulações de fármacos dissuasoras de abuso
|
|
US8753665B2
(en)
|
2004-09-17 |
2014-06-17 |
Durect Corporation |
Controlled delivery system
|
|
GB0421149D0
(en)
*
|
2004-09-23 |
2004-10-27 |
Johnson Matthey Plc |
Preparation of oxycodone
|
|
GB0421687D0
(en)
*
|
2004-09-30 |
2004-11-03 |
Johnson Matthey Plc |
Preparation of opiate analgesics
|
|
WO2006084389A1
(de)
|
2005-02-11 |
2006-08-17 |
Cilag Ltd. |
Verfahren zur reinigung von noroxymorphon-verbindungen
|
|
RS51131B
(sr)
*
|
2005-03-04 |
2010-10-31 |
Euro-Celtique S.A. |
Postupak smanjenja alfa, beta nezasićenih ketona u opioidnim kompozicijama
|
|
AU2006234257B2
(en)
*
|
2005-04-06 |
2011-03-10 |
Toray Industries, Inc. |
Crystals of morphinan derivative and process for producing the same
|
|
US8071768B2
(en)
*
|
2005-06-10 |
2011-12-06 |
Janssen Pharmaceutica, N.V. |
Alkylquinoline and alkylquinazoline kinase modulators
|
|
MX2007015789A
(es)
*
|
2005-06-16 |
2008-02-15 |
Mallinckrodt Inc |
Nueva ruta de sintesis para opiatos de 14-hidroxilo a traves de 1-halo-tebaina o analogos.
|
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
|
US20070117826A1
(en)
*
|
2005-11-23 |
2007-05-24 |
Forest Laboratories, Inc. |
Pharmaceutical formulations comprising ibuprofen, oxycodone, and 14-hydroxycodeinone
|
|
US8871779B2
(en)
|
2006-03-02 |
2014-10-28 |
Mallinckrodt Llc |
Process for preparing morphinan-6-one products with low levels of α,β-unsaturated ketone compounds
|
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
|
NZ575620A
(en)
*
|
2006-09-20 |
2010-11-26 |
Mallinckrodt Inc |
Preparation of substituted morphinan-6-ones and salts and intermediates thereof
|
|
WO2008048711A1
(en)
*
|
2006-10-17 |
2008-04-24 |
Penick Corporation |
Process for preparing oxymorphone
|
|
US20080125592A1
(en)
*
|
2006-10-17 |
2008-05-29 |
Penick Corporation |
Process for preparing oxymorphone, naltrexone, and buprenorphine
|
|
CA2674915C
(en)
|
2006-10-17 |
2015-06-30 |
Penick Corporation |
Process for preparing oxymorphone
|
|
AU2012216358B2
(en)
*
|
2006-10-17 |
2014-11-20 |
Penick Corporation |
Process For Preparing Oxymorphone, Naltrexone and Buprenorphine
|
|
US8337883B2
(en)
|
2006-11-03 |
2012-12-25 |
Durect Corporation |
Transdermal delivery systems
|
|
WO2008070658A1
(en)
*
|
2006-12-04 |
2008-06-12 |
Noramco, Inc. |
Process for preparing oxycodone having reduced levels of 14-hydroxycodeinone
|
|
JP2010511725A
(ja)
*
|
2006-12-04 |
2010-04-15 |
ノランコ・インコーポレーテツド |
オキシコドン塩基中の不純物を減少させる方法
|
|
GB0624880D0
(en)
*
|
2006-12-14 |
2007-01-24 |
Johnson Matthey Plc |
Improved method for making analgesics
|
|
PL2137189T3
(pl)
*
|
2007-03-06 |
2015-12-31 |
SpecGx LLC |
Sposób wytwarzania czwartorzędowych N-alkilowych soli alkaloidu morfinanowego
|
|
US9040726B2
(en)
|
2007-03-06 |
2015-05-26 |
Mallinckrodt Llc |
Process for the preparation of quaternary N-alkyl morphinan alkaloid salts
|
|
CA2681740A1
(en)
*
|
2007-03-23 |
2008-10-02 |
Mallinckrodt Inc. |
Improved preparation of oxymorphone from oripavine
|
|
EP2137190B1
(en)
*
|
2007-04-16 |
2013-06-12 |
Mallinckrodt LLC |
Novel opiate reduction utilizing catalytic hydrogen transfer reaction
|
|
US20090018154A1
(en)
*
|
2007-05-17 |
2009-01-15 |
Endo Pharmaceuticals, Inc., A Corporation Of Delaware |
Opioid and methods of making and using the same
|
|
EP2067471B1
(en)
|
2007-12-06 |
2018-02-14 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
|
WO2009079013A1
(en)
*
|
2007-12-17 |
2009-06-25 |
Mallinckrodt Inc. |
Processes for the production of (+)-'nal' morphinan compounds
|
|
JP5579076B2
(ja)
*
|
2007-12-17 |
2014-08-27 |
マリンクロッド エルエルシー |
シノメニン誘導体およびそれらの合成のためのプロセス
|
|
US7999105B2
(en)
*
|
2008-02-29 |
2011-08-16 |
Mallinckrodt Inc. |
Process for the preparation of 3-hydroxymorphinan derivatives
|
|
ES2373364T3
(es)
*
|
2008-04-24 |
2012-02-02 |
Janssen Pharmaceutica N.V. |
Profármacos de nalmefeno.
|
|
EP2285780B1
(en)
*
|
2008-05-27 |
2015-08-26 |
Mallinckrodt LLC |
Processes and compounds for the preparation of normorphinans
|
|
EP2331508B1
(en)
|
2008-09-03 |
2014-11-12 |
Mallinckrodt LLC |
Substituted berbines and processes for their synthesis
|
|
CA2738246C
(en)
*
|
2008-09-30 |
2017-09-05 |
Mallinckrodt Inc. |
Processes for the alkylation of secondary amine groups of morphinan derivatives
|
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
|
UA102916C2
(uk)
|
2009-07-02 |
2013-08-27 |
Кемфарм, Інк. |
Композиція на основі кон'югату гідрокодону з бензойною кислотою, похідними бензойної кислоти або гетероарилкарбоновою кислотою, проліки, спосіб лікування від зловживань
|
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
|
JP5736040B2
(ja)
|
2010-06-11 |
2015-06-17 |
ローズ テクノロジーズ |
Ｎ−アリル化合物の調製のための遷移金属触媒プロセスおよびその使用
|
|
CA2802294C
(en)
|
2010-06-11 |
2016-05-10 |
Rhodes Technologies |
Process for n-dealkylation of tertiary amines
|
|
EP2588481B1
(en)
|
2010-07-02 |
2017-11-15 |
Johnson Matthey Public Limited Company |
Process for the synthesis and purification of oxycodone
|
|
RU2448709C1
(ru)
*
|
2011-02-01 |
2012-04-27 |
Учреждение Российской академии наук Институт проблем химико-энергетических технологий Сибирского отделения РАН (ИПХЭТ СО РАН) |
Способ получения налтрексона
|
|
TWI560170B
(en)
*
|
2011-12-06 |
2016-12-01 |
Lundbeck & Co As H |
Process for recovery of nalmefene hydrochloride
|
|
US9315514B2
(en)
|
2012-08-27 |
2016-04-19 |
Rhodes Technologies |
1,3-dioxanomorphides and 1,3-dioxanocodides
|
|
JP6163210B2
(ja)
|
2012-12-14 |
2017-07-12 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
窒素含有モルフィナン誘導体およびその使用
|
|
CA2894963A1
(en)
|
2012-12-14 |
2014-06-19 |
Purdue Pharma L.P. |
Pyridonemorphinan analogs and biological activity on opioid receptors
|
|
ES2621305T3
(es)
|
2012-12-14 |
2017-07-03 |
Purdue Pharma Lp |
Morfinanos espirocíclicos y su uso
|
|
WO2014102587A1
(en)
|
2012-12-28 |
2014-07-03 |
Purdue Pharma L.P. |
7,8-cyclicmorphinan analogs
|
|
CA2896202A1
(en)
|
2012-12-28 |
2014-07-03 |
Purdue Pharma L.P. |
Substituted morphinans and the use thereof
|
|
ES2748803T3
(es)
|
2012-12-31 |
2020-03-18 |
Rhodes Tech |
Procedimiento para preparar 6,14-etenomorfinanos sustituidos en 7, 6,14-etanomorfinanos sustituidos en 7
|
|
HK1220579A1
(zh)
|
2013-03-15 |
2017-05-12 |
Durect Corporation |
用於降低溶解可变性的具有流变改性剂的组合物
|
|
EP2829541A1
(en)
|
2013-07-26 |
2015-01-28 |
Siegfried AG |
Novel synthesis of noroxymorphone from morphine
|
|
US9120800B2
(en)
|
2013-08-02 |
2015-09-01 |
Johnson Matthey Public Limited Company |
Process for the preparation of oxymorphone alkaloid and oxymorphone salts
|
|
US9340542B2
(en)
|
2013-12-26 |
2016-05-17 |
Purdue Pharma L.P. |
Propellane-based compounds and the use thereof
|
|
US9988392B2
(en)
|
2013-12-26 |
2018-06-05 |
Purdue Pharma L.P. |
7-beta-alkyl analogs of orvinols
|
|
WO2015097545A1
(en)
|
2013-12-26 |
2015-07-02 |
Purdue Pharma L.P. |
Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans
|
|
US9994571B2
(en)
|
2013-12-26 |
2018-06-12 |
Purdue Pharma L.P. |
10-substituted morphinan hydantoins
|
|
EP3089978B1
(en)
|
2013-12-30 |
2018-08-29 |
Purdue Pharma L.P. |
Pyridone-sulfone morphinan analogs as opioid receptor ligands
|
|
NZ731591A
(en)
|
2014-11-25 |
2018-06-29 |
Kempharm Inc |
Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxycodone
|
|
EP3252055B1
(en)
|
2016-05-31 |
2018-09-19 |
Alcaliber Investigacion Desarrollo e Innovacion SLU |
Process for obtaining 3,14-diacetyloxymorphone from oripavine
|
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
|
CN109475505A
(zh)
|
2016-07-06 |
2019-03-15 |
度瑞公司 |
具有药物组成物、屏障层及药物层的口服剂型
|
|
CN110198945B
(zh)
|
2016-12-23 |
2023-06-27 |
米尼奥尔克斯治疗有限公司 |
用于制备噻唑烷二酮化合物及其盐的方法
|
|
SK592017A3
(sk)
|
2017-07-04 |
2019-01-08 |
Saneca Pharmaceuticals A. S. |
Spôsob prípravy morfínanových zlúčenín
|
|
US11845759B2
(en)
|
2018-02-23 |
2023-12-19 |
Rhodes Technologies |
Opioid compounds and uses thereof
|
|
CN110054656B
(zh)
*
|
2019-05-28 |
2021-02-02 |
宜昌人福药业有限责任公司 |
一种10-羰基/羟基吗啡-6-葡萄糖苷酸的合成方法
|
|
US11613547B2
(en)
|
2019-07-08 |
2023-03-28 |
University Of Health Sciences & Pharmacy In St. Louis |
G-protein biased opioid receptor agonist/analgesics with reduced arrestin recruitment
|
|
CN115666621A
(zh)
|
2020-01-13 |
2023-01-31 |
度勒科特公司 |
具有减少的杂质的持续释放药物递送系统及相关方法
|
|
CN114621239A
(zh)
*
|
2020-12-10 |
2022-06-14 |
鲁南制药集团股份有限公司 |
一种纳曲酮的制备方法
|
|
JP2024501153A
(ja)
*
|
2020-12-28 |
2024-01-11 |
ナヴィン サクセナ リサーチ アンド テクノロジー ピーブイティー．エルティーディー． |
モルヒネからのノルオキシモルフォンの合成のための新規方法
|